Physician in the Loop: Pediatrics

The Food and Drug Administration (FDA) on Oct. 1 approved the Autus Size-Adjustable Valve, the first heart valve designed to be expanded after surgery to keep pace with a child's growth. In JAMA, the PRESSURE trial found no significant difference in 30-day mortality and ventilation duration with a permissive pediatric intensive care blood pressure target, which cut norepinephrine-equivalent dose 37.5%. The Centers for Disease Control and Prevention (CDC) counted 3,887 measles cases this year as of Oct. 1, and the FDA approved the first treatment for MCT8 deficiency.

Read this week's roundup and its sources: https://physicianintheloop.org/specialties/pediatrics/2026-09-28/

The voices on this episode are generated by AI, and so is the script, from the week's specialty roundup at Physician in the Loop. Every fact in the roundup links to its source.